Search Results - "Lastre, M"

Refine Results
  1. 1

    Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii by Batista-Duharte, A., Lastre, M., Romeu, B., Portuondo, D.L., Téllez-Martínez, D., Manente, F.A., Pérez, O., Carlos, I.Z.

    Published in International immunopharmacology (01-11-2016)
    “…Introduction: Sporotrichosis is an emergent subcutaneous mycoses caused by species of the Sporothrix schenckii complex. Amphotericin B (AmB) remains the main…”
    Get full text
    Journal Article
  2. 2

    Environmental Persistence of the Antidepressant Fluoxetine and Its Pharmaceutical Alternative: Kinetics of Oxidation and Mathematical Simulations by Larissa P. Souza, João G. M. Carneiro, Arlen M. Lastre-Acosta, Bruno Ramos, Antonio C. S. C. Teixeira

    Published in Water (Basel) (01-11-2022)
    “…To investigate the impact of antidepressants (ANT) in water, estimates of the direct and indirect photolysis of standard fluoxetine hydrochloride (FLX) and a…”
    Get full text
    Journal Article
  3. 3

    Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations by Pérez, O, Batista-Duharte, A, González, E, Zayas, C, Balboa, J, Cuello, M, Cabrera, O, Lastre, M, Schijns, V E J C

    “…Adjuvants have been considered for a long time to be an accessory and empirical component of vaccine formulations. However, accumulating evidence of their…”
    Get full text
    Journal Article
  4. 4

    A vaccine against S. pyogenes: Design and experimental immune response by Guilherme, L., Postol, E., Freschi de Barros, S., Higa, F., Alencar, R., Lastre, M., Zayas, C., Puschel, C.R., Silva, W.R., Sa-Rocha, L.C., Sa-Rocha, V.M., Pérez, O., Kalil, J.

    Published in Methods (San Diego, Calif.) (01-12-2009)
    “…Streptococcus pyogenes causes severe invasive infections: the post-streptococcal sequelae of acute rheumatic fever (RF) and rheumatic heart disease (RHD),…”
    Get full text
    Journal Article
  5. 5

    New Vaccines Require Potent Adjuvants like AFPL1 and AFCo1 by Pérez, O, Lastre, M, Cabrera, O, del Campo, J, Bracho, G, Cuello, M, Balboa, J, Acevedo, R, Zayas, C, Gil, D, Mora, N, González, D, Pérez, R, González, E, Barberá, R, Fajardo, E.M, Sierra, G, Solís, R.L, Campa, C

    Published in Scandinavian journal of immunology (01-08-2007)
    “…Neisseria meningitidis B proteoliposome (AFPL1 when used as adjuvant) and its derivative-Cochleate (AFCo1) contain immunopotentiating and immunomodulating…”
    Get full text
    Journal Article
  6. 6

    Immune Response Induction and New Effector Mechanisms Possibly Involved in Protection Conferred by the Cuban Anti-Meningococcal BC Vaccine by PEREZ, Oliver, LASTRE, Miriam, LAPINET, José, BRACHO, Gustavo, DIAZ, Miriam, ZAYAS, Caridad, TABOADA, Carlos, SIERRA, Gustavo

    Published in Infection and Immunity (01-07-2001)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  7. 7

    Aqueous picloram degradation by hydroxyl radicals: Unveiling mechanism, kinetics, and ecotoxicity through experimental and theoretical approaches by Sanches-Neto, Flávio O., Ramos, Bruno, Lastre-Acosta, Arlen M., Teixeira, Antonio Carlos S.C., Carvalho-Silva, Valter H.

    Published in Chemosphere (Oxford) (01-09-2021)
    “…Pesticides are chemical compounds widely used to combat pests in crops, and they thus play a key role in agricultural production. However, due to their…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Neisseria meningitidis serogroup B lipopolysaccharides induce a lower pro-inflammatory effect within the proteoliposome used in Cuban anti-meningococcal vaccines by Pérez, O., Graham, S., Lastre, M., Ellis, C.D., Pupo, R.R., Tellez-Martínez, D., Batista-Duharte, A.

    Published in Vacunas (Barcelona. Internet. English ed.) (01-07-2018)
    “…Neisseria meningitidis outer membrane vesicles or proteoliposomes (PLs) have been used as vaccines and adjuvants. Despite the presence of potentially toxic…”
    Get full text
    Journal Article
  10. 10

    Neisseria meningitidis serogroup B lipopolysaccharides induce a lower pro-inflammatory effect within the proteoliposome used in Cuban anti-meningococcal vaccines by Pérez, O., Graham, S., Lastre, M., Ellis, C.D., Pupo, R.R., Tellez-Martínez, D., Batista-Duharte, A.

    Published in Vacunas (01-07-2018)
    “…Neisseria meningitidis outer membrane vesicles or proteoliposomes (PLs) have been used as vaccines and adjuvants. Despite the presence of potentially toxic…”
    Get full text
    Journal Article
  11. 11

    Angiostrongylus cantonensis: role of eosinophils in the neurotoxic syndrome (Gordon-like phenomenon) by Perez, O, Capron, M, Lastre, M, Venge, P, Khalife, J, Capron, A

    Published in Experimental parasitology (01-05-1989)
    “…The role of eosinophils in the pathophysiology of Angiostrongylus cantonensis infections was investigated in nonpermissive (guinea pig) and permissive (rat)…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14

    Total and specific IgE in serum and cerebrospinal fluid of rats and guinea pigs infected with Angiostrongylus cantonensis by Pérez, O, Lastre, M, Capron, M, Neyrinck, J L, Jouault, T, Bazin, H, Capron, A

    Published in Parasitology research (1987) (01-01-1989)
    “…The total and specific IgE response to Angiostrongylus cantonensis infection was evaluated according to host permissiveness. Total IgE levels measured by a…”
    Get full text
    Journal Article
  15. 15

    Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations by O. Pérez, A. Batista-Duharte, E. González, C. Zayas, J. Balboa, M. Cuello, O. Cabrera, M. Lastre, V.E.J.C. Schijns

    “…Adjuvants have been considered for a long time to be an accessory and empirical component of vaccine formulations. However, accumulating evidence of their…”
    Get full text
    Journal Article
  16. 16

    Proteoliposome derived cochleate as novel adjuvant by Bracho, Gustavo, Lastre, Miriam, Campo, Judith del, Zayas, Caridad, González, Domingo, Gil, Danay, Acevedo, Reinaldo, Taboada, Carlos, Solís, Rosa L, Pérez, Oliver

    Published in Vaccine (01-04-2006)
    “…Cochleate structures (CS) consist in a highly stable lipid structures that have been reported to be a good antigen delivery system. The incorporation of…”
    Get full text
    Journal Article
  17. 17

    Bacterial derived proteoliposome for allergy vaccines by Lastre, Miriam, Pérez, Oliver, Labrada, Alexis, Bidot, Igor, Pérez, Jorge, Bracho, Gustavo, Campo, Judith del, Pérez, Dainerys, Facenda, Elisa, Zayas, Caridad, Rodríguez, Claudio, Sierra, Gustavo

    Published in Vaccine (01-04-2006)
    “…One current approach in developing anti allergic vaccines is the use of potent adjuvants, capable of inducing Th1 or T regulatory cells. Proteoliposomes (PL)…”
    Get full text
    Journal Article
  18. 18

    Immunological evaluation of bacterial derived Cochleate and Proteoliposome as mucosal adjuvants by del Campo, Judith, Lastre, Miriam, Bracho, Gustavo, Rodríguez, Tamara, Gil, Danay, Zayas, Caridad, Taboada, Carlos, Acevedo, Reinaldo, Pérez, Danev Ricardo, Pérez, Oliver

    Published in Vaccine (01-04-2006)
    “…We evaluated the potential of two bacterial derived compounds, Cochleate and Proteoliposome (PL), administrated to mice by nasal or oral routes on induction of…”
    Get full text
    Journal Article
  19. 19

    Strategy for determination of an efficient Cochleate particle size by Gil, Danay, Bracho, Gustavo, Zayas, Caridad, del Campo, Judith, Acevedo, Reinaldo, Toledo, Arturo, Lastre, Miriam, Pérez, Oliver

    Published in Vaccine (01-04-2006)
    “…Cochleate structures obtained from the outer membrane of Neisseria meningitidis serotype B have demonstrated to be high immunogenicity when administrated by…”
    Get full text
    Journal Article
  20. 20